PyroGenesis Announces Completion of Ramp-Up Phase of 1st Plasma Atomization System

PyroGenesis Canada (TSXV:PYR) has announced it has completed the ramp-up phase of its first plasma atomization system.
As quoted in the press release:

During the ramp-up, the following were also achieved:

• Six (6) Non-Disclosure Agreements (“NDA”) signed with distributors and 3D printer manufacturers
• Three (3) NDAs being negotiated with multinational aircraft engine manufacturers, at their request
• Exclusive distributorship under negotiation in Asia
• Received six (6) sample orders for metal powder, of which five (5) have been delivered to date
• Adjusted process for other metal powders (i.e. Inconel)
• Developed new, potentially game changing, intellectual property; Patent applications progressing as expected

Mr. P. Peter Pascali, President and CEO of PyroGenesis, provides an overview of today’s announcement in the following Q&A format. The questions, for the most part, are derived from inquiries received from investors, analysts, and potential customers:
Q: You announce today that ramp-up is complete? What does that mean exactly?
A: It means that we are open for business. By announcing the end of ramp-up, the plasma atomization reactor is fully functional, and ready to operate 24/7. We have added a second shift in anticipation of large scale commercial orders. The feedback so far is that our powders are of exceptional quality and, given our capacity for innovation, we offer extremely competitive pricing. As previously noted, we are already in discussion with numerous players in the field.
Q. In terms of your sales strategy, do you plan on targeting metal 3D printer manufacturers, end users such as GE, distributors, or all the above?
A. As noted above, we have signed six (6) NDAs with both distributors and 3D printer manufacturers and three (3) NDAs are currently being negotiated with multinational aircraft engine manufacturers.
PyroGenesis’ strategy in the beginning of 2016, when we first announced that we were reentering the business of producing the very same powders we once produced for ourselves and the biomedical industry, was simply to be a credible second supplier. It only made good business sense for companies to have a second supplier for a vital feedstock such as titanium powders, and we wanted to fill that role.

Click here to read the full press release.